• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC ONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC ONE Back to Search Results
Lot Number 218288302
Device Problem Insufficient Information (3190)
Patient Problems Nausea (1970); Pain (1994); Vomiting (2144); Weakness (2145); Dizziness (2194); Joint Swelling (2356)
Event Date 11/13/2017
Event Type  Injury  
Event Description
Bilateral knee injections received on (b)(6) 2017.One hour after injections patient experienced pain, swelling, generalized weakness, light headedness, n/v, tingling in feet.Dose or amount: 6 ml millilitre(s).Frequency: other - once.Route: intra-articular.Therapy start date: (b)(6) 2017.Therapy end date: (b)(6) 2017.Diagnosis or reason for use: arthritis of knees.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
SYNVISC ONE
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key7154363
MDR Text Key96177207
Report NumberMW5074280
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 12/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot Number218288302
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age45 YR
Patient Weight107
-
-